Whether you’re a strategic partner, accredited investor, clinician, or scientist — we’d love to hear from you.
We typically respond within two business days.
For partnership inquiries, data-room access, and accredited investor materials.
A full data package — including preclinical study reports, IP filings, and financial projections — is available under a mutual NDA on request.
A preclinical-stage biopharmaceutical company developing first-in-class, shelf-stable wound healing therapeutics — making advanced care accessible everywhere.
